# Helminth-induced Immunomodulation Therapy (HINT) in Relapsing-remitting Multiple Sclerosis

> **NCT00645749** · PHASE1 · COMPLETED · sponsor: **University of Wisconsin, Madison** · enrollment: 17 (actual)

## Conditions studied

- Relapsing Remitting Multiple Sclerosis

## Interventions

- **BIOLOGICAL:** Helminth ova

## Key facts

- **NCT ID:** NCT00645749
- **Lead sponsor:** University of Wisconsin, Madison
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-07
- **Primary completion:** 2015-08-13
- **Final completion:** 2015-08-13
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2019-02-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00645749

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00645749, "Helminth-induced Immunomodulation Therapy (HINT) in Relapsing-remitting Multiple Sclerosis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00645749. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*